AHL Partners’s Innoviva INVA Stock Holding History

AHL Partners’s Portfolio INVA Stock Details INVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-10,256	Closed	-$145K	–	1298
2017 Q3	$145K	Buy	+10,256	New	+$136K	﹤0.01%	1213

Other funds holding INVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

AHL Partners's INVA Position: Q4 2017 in Review

AHL Partners sold out of Innoviva (INVA) in Q4 2017, closing a stake of 10,256 shares — an estimated $145K sold.

AHL Partners first reported a position in INVA in Q3 2017 and held it in 1 quarter. The position peaked at $145K in Q3 2017. 200 funds tracked by Wall St. Rank hold INVA as of Q4 2017.

AHL Partners reported no remaining Innoviva position as of Q4 2017 after selling out during the quarter.
AHL Partners sold 10,256 Innoviva shares in Q4 2017, an estimated $145K.
AHL Partners first reported a position in Innoviva in Q3 2017 and held it in 1 quarter.
AHL Partners's Innoviva position peaked at $145K in Q3 2017.
200 funds tracked by Wall St. Rank held Innoviva as of Q4 2017.

Based on AHL Partners's 13F filing for Q4 2017, filed 14 Feb 2018.